Basic HTML Version
A 360°, all-encompassing,
consistent service offering
LISI MEDICAL is now the only market player
able to offer a fully integrated offer, from
the raw material to the packaged and sterile
implant, ready for the operating room.
LISI MEDICAL is currently positioned as a partner that can provide
both very specific industrial responses and a very broad range
of services that enable it to master the entire production chain,
from design to the delivery of implants and ancillaries directly in
the hospitals. The division’s teams are now involved upstream
of the production lifecycle and offer related services such as
co-development, prototyping and the porting of regulatory
responsibility (EC marking, 510K pre-market notification for the
U.S. market, etc.). LISI MEDICAL is also capable of offering,
via
its Moroccan site, generic solutions for emerging markets. This
approach, altogether technological, industrial and commercial, is
an integral part of the differentiation strategy implemented by
LISI MEDICAL to maintain and strengthen its competitive edge.
The division’s ambition is to continue to differentiate itself by
developing new technologies and expanding its offer, from raw
materials to packaged, sterilized finished products.
From raw materials to the operating
room
The comprehensive service offer set up in Caen (LISI MEDICAL
Orthopaedics) allows us to offer our customers the full
management of the post-industrial treatment of implants: LISI
MEDICAL supervises the double packaging in a clean room (Iso
7 and Iso 8 class) of the delivered products. LISI MEDICAL is the
only implant manufacturer whose level of integration guarantees
sterile delivery to the operating room. All these operations are
grouped on the same site, where the division has decided to
Program for
operational
improvement in
Neyron
LISI MEDICAL Fasteners Europe’s site, based in Neyron,
north of Lyon, benefited in 2011 from the establishment
of a comprehensive plan to improve operational
efficiency. Several “KAIZEN” sites were opened there as
part of an ongoing improvement process. Various lean
manufacturing tools have helped to organize production
in manufacturing islets, grouped by line of business
and product, thus ensuring uniform circuits from the
raw material to the finishing. In 2011, the targets in
terms of reduction of the internal manufacturing lead
times, reduction of work in progress and increase in the
versatility of employees, were achieved in the four islets
that areoperational today. In2012, this industrial strategy
will create four additional islets including in particular
the creation of a dedicated unit for implantable plastics
to meet the spine market’s requirements.